Lazeta en es it fr

Lazeta Brand names, Lazeta Analogs

Lazeta Brand Names Mixture

  • No information avaliable

Lazeta Chemical_Formula

C26H28N2

Lazeta RX_link

No information avaliable

Lazeta fda sheet

Lazeta msds (material safety sheet)

Lazeta Synthesis Reference

No information avaliable

Lazeta Molecular Weight

368.514 g/mol

Lazeta Melting Point

No information avaliable

Lazeta H2O Solubility

750 mg/L

Lazeta State

Solid

Lazeta LogP

5.63

Lazeta Dosage Forms

No information avaliable

Lazeta Indication

For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.

Lazeta Pharmacology

Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonists at histamine H1 receptors may be divided into first (sedating) and second (non-sedating) generation agents. Some, such as Cinnarizine also block muscarinic acetylcholine receptors and are used as anti-emetic agents. Cinnarizine through its calcium channel blocking ability also inhibits stimulation of the vestibular system.

Lazeta Absorption

No information avaliable

Lazeta side effects and Toxicity

No information avaliable

Lazeta Patient Information

No information avaliable

Lazeta Organisms Affected

Humans and other mammals